Evolution of Movement Disorders in Patients With CLN2-Batten Disease Treated With Enzyme Replacement Therapy.
Robert V V SpaullAudrey K SooSpyros BatziosEmma FootittRebecca WhiteleyJonathan W MinkLucinda CarrPaul GissenManju A KurianPublished in: Neurology (2024)
Movement disorders are a core feature of CLN2-disease and follow a typical pattern of progression which is slowed by ERT. Identifying and treating movement disorders should become standard, especially given increased patient survival.